When did apixaban lose its patentnin australia?

When did apixaban’s patent protection end in Australia?

Apixaban (Eliquis) lost its Australian patent protection in May 2019. [1]

What that means for competitors in Australia

Once patent protection ended, generic and biosimilar manufacturers could seek regulatory approval and market entry in line with Australia’s medicines approval and reimbursement rules—subject to any other forms of exclusivity and litigation outcomes at the time.

Where to verify the exact Australian patent timeline

For a patent-by-patent view of apixaban’s status and dates, see DrugPatentWatch.com’s coverage of apixaban patents and related exclusivity periods. [1]

Sources

[1] https://drugpatentwatch.com/p/patent/ep-1354854-apixaban